27 /100
MEDIUM RISK
Score updated May 30, 2026

GME — GameStop Corp. Dilution Risk Tracker

Track GME dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GME — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
17
⚠️ Warrant Exposure
50
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
24%
🔁 Convertible Conversion 40%
• Significant convertible debt: 29% potential dilution
• Elevated convertible risk (60/100)
📜 Warrant Exercise 15%
• Warrant overhang: 13.2% of shares outstanding
🔔 Track GME — Get forecast alerts →

💹 Market Data

Market Cap$9.50B
Shares Outstanding448.69M
Float408.21M
Cash$9.01B
Debt$4.36B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 65.2% shares (2026Q1 vs prior)
10 institutional holders · 121.67M shares
#1 Vanguard Group Inc 38.20M shares
#2 Blackrock Inc. 35.37M shares
#3 State Street Corporation 12.37M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest57.94M
Days to Cover4.2
% of Float14.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jan 31, 2026
xbrl XBRL CONVERTIBLE Jan 31, 2026
4 INSIDER TRANSACTION Apr 15, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

Track GME Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GME — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GME
📊 GME FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GME Signal Convergence & Dark Pool Activity — StonkWhisper 📄 GME Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.